STAT+: Amgen pricing for its Humira biosimilar may benefit PBMs and insurers more than patients
STAT
JANUARY 31, 2023
Here’s why: The drug company will offer its medication, called Amjevita, at two different discounts – 5% and 55% – off the roughly $80,000 wholesale, or list, price. Continue to STAT+ to read the full story…
Let's personalize your content